Prime Medicine Ratios (2021-2025) | PRME

Ratios Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -7,720.30%-25,128.23%-1,936.60%-3,568.78%-4,716.68%-4,312.82%
EBIT Margin -8,179.53%-25,948.33%-2,025.74%-3,603.30%-4,787.17%-4,405.96%
EBITDA Margin -7,756.51%-25,084.21%-1,937.52%-3,569.88%-4,716.23%-4,125.63%
Operating Margin -8,179.53%-25,948.33%-2,025.74%-3,603.30%-4,787.17%-4,405.96%
Net Margin -7,742.98%-25,128.23%-1,936.60%-3,568.78%-4,716.68%-4,129.14%
FCF Margin -11,849.58%-13,009.09%662.12%-3,526.75%-3,855.07%-2,880.49%
Efficiency
Assets Average 287.79M338.63M298.91M260.00M216.50M252.62M285.54M296.24M315.15M312.84M303.59M332.01M
Equity Average -125.33M-161.59M-181.00M-209.08M46.59M297.54M259.45M217.03M163.51M188.42M220.18M193.05M171.33M130.04M83.89M111.34M
Invested Capital -94.42M-156.24M-166.94M-195.06M-223.10M316.27M278.80M240.10M193.96M133.07M243.77M196.59M189.50M153.15M106.92M60.86M161.82M
Asset Utilization Ratio 0.010.020.02
Leverage & Solvency
Equity Ratio -0.52-1.040.880.880.850.810.690.780.760.570.510.330.220.42
Valuation
Enterprise Value -200.66M-253.66M-164.25M-92.24M-137.12M1,520.04M952.74M1,223.18M767.74M746.08M635.47M458.78M293.90M195.55M120.67M225.95M537.11M
Market Capitalization 1,806.13M1,196.12M1,424.41M928.24M862.29M839.57M616.96M464.52M382.99M261.01M324.30M745.54M
Return Ratios
Return on Sales -45.53%-40.17%-33.39%
Return on Capital Employed -0.45%-0.43%-0.58%-0.80%-1.28%-0.93%-0.84%-0.88%-0.73%-0.74%-0.76%-0.69%
Return on Invested Capital 0.64%-2.48%-0.46%-0.60%-0.81%-1.13%-1.01%
Return on Assets -0.42%-0.41%-0.50%-0.66%-0.92%-0.81%-0.76%-0.74%-0.62%-0.65%-0.66%-0.60%
Return on Equity 0.73%0.70%-2.61%-0.46%-0.58%-0.79%-1.21%-1.09%-0.99%-1.14%-1.14%-1.55%-2.38%-1.79%